Wire · founder news, decoded · opportunities
FDA Clears HoneyNaps Ai Software for Sleep Apnea Analysis | RT
FDA cleared HoneyNaps' Somnum V3.0 AI software for automated detection and classification of obstructive, central, and mixed sleep apnea with 97% accuracy. The tool assists healthcare professionals in polysomnography analysis and the company plans to add hypoxic, arousal, and ventilatory burden markers in future versions.
This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.
The Wire takeaway
If you build sleep diagnostic hardware or sell into sleep labs, your workflow just became a target for displacement. HoneyNaps has proven FDA will clear AI that replaces manual scoring — the next vendor to hit this market will hunt for your installed base.
Read the full story at respiratory-therapy.com →
Topics: Digital Health · fda-510k-clearance · sleep-apnea-ai · diagnostic-automation · clinical-decision-support · polysomnography